CybeRelease: (OTC: BANY) Announces Record Revenues for the Month Ended February 2006

(CybeRelease, March 28, 2006) - Lake Harmony, PA - Banyan Corporation (OTC BB: BANY) is pleased to announce record revenues for the month ended February, 2006. Consolidated revenues from Banyan subsidiary companies, Chiropractic USA, Diagnostic USA, plus the recently acquired Premier Medical Group LLC, were approximately $438,171.80 (unaudited) vs. $26,774.24 for the same month last year, an increase of over $400,000 over February 2005. This substantial jump in revenues was driven principally through the addition of revenues from our newest addition to Banyan - Premier Medical group, effective February 10, 2006 as well as a significant increase in Chiropractic USA royalty income.

Premier has been operating since 1993 and is one of the largest electro-diagnostic testing companies in the country. Premier, which operates in 30 states and has tested for over 3500 physicians, has a history of significant profitability.

Commenting on the February revenue numbers, Banyan CEO Michael Gelmon said, "We are pleased to see the immediate impact on our top line revenues from our recent acquisition of Premier Medical Group, in addition to the continued improvement in our other subsidiaries, Chiropractic USA and Diagnostic USA. We have big plans for Premier on a go-forward basis and expect significant further revenue growth. Based on current projections, we expect Banyan to be profitable by the 2nd Quarter of this year.”
For more information, go to www.cyberelease.com/bany32806.htm.

CybeRelease Gainers are James Monroe Bancorp Inc. (Nasdaq: JMBI), SIGA Technologies Inc. (Nasdaq: SIGA), Kopin Corporation (Nasdaq: KOPN), Exide Technologies (Nasdaq: EXFO), LanOptics Ltd. (Nasdaq: LNOP), SRI/Surgical Express, Inc. (Nasdaq: STRC), Olympic Steel, Inc. (Nasdaq: ZEUS) and Smith Micro Software, Inc. (Nasdaq: SMSI).

CybeRelease Decliners are Encysive Pharmaceuticals Inc. (Nasdaq: ENCY), Heska Corporation (Nasdaq: HSKA), Generex Biotechnology Corporation (Nasdaq: GNBT), American Claims Evaluation, Inc. (Nasdaq: AMCE), Carrington Laboratories, Inc. (Nasdaq: CARN), Tollgrade Communications, Inc. (Nasdaq: TLGD), Avigen, Inc. (Nasdaq: AVGN) and Big Dog Holding, Inc. (Nasdaq: BDOG).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $795.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail